Chapter 12 principles of pharmacology

Option C: Elimination half life of a drug = 0.693 Vd divided by CLs accurately describes the relationship between half-life, volume of distribution, and clearance. This formula is essential in pharmacokinetics for determining how long a drug remains active in the body, guiding dosing intervals and adjustments.

Option A: Loading dose = steady state concentration (Css) x clearance (CLs) misrepresents the formula for calculating a loading dose, which should actually be Css x Vd. This is critical for achieving therapeutic levels quickly.

Option B: Maintenance dose = steady state concentration (Css) x volume of distribution (Vd) incorrectly states the relationship; the maintenance dose should be calculated using Css and clearance (CLs) to maintain therapeutic levels over time.

Option D: Drugs with zero order kinetics have a fixed half life is misleading; zero order kinetics indicates that the rate of elimination is constant regardless of concentration, leading to variable half-lives depending on the drug concentration.

Takeaways: Understanding the pharmacokinetic principles, such as the relationship between elimination half-life, volume of distribution, and clearance, is crucial for effective medication management and dosing strategies, as outlined in this resource on pharmacokinetics.

Option D: Hepatic extraction is a main determinant of bioavailability (F) following oral administration, as it reflects the extent to which a drug is metabolized by the liver before reaching systemic circulation. High hepatic extraction can significantly reduce the amount of active drug available in the bloodstream, impacting therapeutic efficacy.

Option A: Systemic clearance (CLs) pertains to the volume of plasma cleared of the drug per unit time but does not directly influence the bioavailability of a drug after oral administration.

Option B: Volume of distribution (Vd) describes the distribution of a drug throughout the body's fluids and tissues, but it does not determine the bioavailability following oral administration.

Option C: Half-life (t1/2) indicates the time required for the concentration of the drug in the bloodstream to reduce by half, but it does not directly affect the bioavailability of a drug after oral dosing.

Takeaways: Understanding hepatic extraction as a determinant of bioavailability (F) is crucial for predicting drug effectiveness and requires consideration of first-pass metabolism when evaluating oral medications.

Option C: Imipramine possesses anticholinergic effects but fluoxetine does not, making it effective in treating nocturnal enuresis. The anticholinergic properties of imipramine help reduce bladder contractions, thus decreasing episodes of bedwetting, while fluoxetine lacks these effects and is primarily an antidepressant with different indications.

Option A: Imipramine does not induce insomnia; rather, it can cause sedation. Fluoxetine is known to have activating effects, which can lead to insomnia, making this statement factually inaccurate.

Option B: Imipramine is not necessarily safer than fluoxetine; both medications have distinct safety profiles and potential side effects. The safety of a medication depends on the specific clinical context and patient factors.

Option D: Not all statements are true, as options A and B contain inaccuracies. Therefore, this option cannot be correct as it implies that all preceding statements are valid.

Takeaways: Understanding the pharmacological differences between imipramine and fluoxetine is crucial, particularly regarding their effects on the bladder and treatment of nocturnal enuresis, which requires knowledge of anticholinergic properties for effective management.

Option A: Oxytetracycline's systemic bioavailability is significantly enhanced when taken in a fasting state due to reduced competition for absorption in the gastrointestinal tract. Food can bind to oxytetracycline, decreasing its absorption and effectiveness. Therefore, administration on an empty stomach maximizes its therapeutic potential.

Option B: Amoxicillin's absorption is not significantly affected by food intake, as it maintains good bioavailability regardless of whether it is taken with or without food. This characteristic allows for flexibility in dosing.

Option C: Levodopa's absorption can be impaired by high-protein meals, which compete for transport across the gut. Therefore, it is often recommended to take levodopa on an empty stomach for optimal absorption, but it is not specifically increased in a fasting state like oxytetracycline.

Option D: Acetylsalicylic acid (aspirin) does not have its systemic bioavailability significantly increased in a fasting state. Its absorption is relatively stable regardless of food intake, and it can be taken with or without food depending on patient tolerance.

Takeaways: Understanding that oxytetracycline's absorption is maximized in a fasting state due to reduced food interaction highlights the importance of proper medication administration timing, which requires patient education on medication timing to ensure optimal therapeutic outcomes.

Option C: Technetium-99m (Tc) is the most commonly used radionuclide in nuclear pharmacy practice due to its favorable physical properties, including a half-life of 6 hours and gamma emission, which makes it ideal for diagnostic imaging. Its widespread application in various imaging modalities enhances its utility in clinical settings.

Option A: Gallium-67 (Ga) is used in specific imaging scenarios, particularly for detecting infections and tumors, but it is not as commonly utilized as Technetium-99m in routine nuclear pharmacy practice.

Option B: Thallium-201 (Tl) is primarily used in cardiac imaging but has a more limited application compared to Technetium-99m, making it less common in general nuclear pharmacy use.

Option D: Iodine-123 (I) is utilized in thyroid imaging and treatment, but its use is not as prevalent as Technetium-99m, which is the standard for a wide range of diagnostic procedures.

Takeaways: Technetium-99m is the cornerstone of nuclear pharmacy practice due to its optimal characteristics for imaging, which requires understanding its applications in diagnostic procedures for effective patient care.

Option C: Tachyphylaxis refers to the rapid decrease in response to a drug after its repeated administration. In the case of calcitonin, its effectiveness diminishes significantly within 2 to 3 days of continuous use, necessitating the addition of a bisphosphonate for sustained treatment of hypercalcemia.

Option A: Anaphylaxis is a severe allergic reaction that occurs suddenly and can be life-threatening. It does not describe a decrease in drug effectiveness.

Option B: Prophylaxis refers to measures taken to prevent disease or a condition. It does not pertain to the diminishing response to a medication.

Option D: Tolerance is a gradual decrease in response to a drug that occurs over time with continued use, unlike tachyphylaxis, which happens rapidly.

Takeaways: Understanding tachyphylaxis is crucial in pharmacology, particularly when managing conditions like hypercalcemia, as it requires appropriate adjustments in treatment strategies to maintain efficacy.

Option D: The loading dose (D_L) of a drug is determined by the apparent volume of distribution (V_D) and the desired drug concentration in plasma. This calculation ensures that the initial concentration of the drug reaches therapeutic levels quickly, which is crucial for effective treatment.

Option A: Total body clearance (Cl_T) influences the maintenance dose rather than the loading dose, as it relates to how quickly the drug is eliminated from the body.

Option B: The percentage of drug bound to plasma proteins affects the drug's free concentration but does not directly determine the loading dose, which is based on volume of distribution and target plasma concentration.

Option C: The fraction of drug excreted unchanged in the urine pertains to the drug's elimination pathway and does not factor into the calculation of the loading dose, which focuses on achieving a specific plasma concentration.

Takeaways: The loading dose of a drug is calculated using the apparent volume of distribution and the desired plasma concentration, which requires understanding pharmacokinetics for effective dosing to ensure therapeutic efficacy.

Option A: Glucuronidation is a metabolic reaction that remains functional in elderly patients, making it a key pathway for morphine metabolism. This phase II reaction is less affected by aging compared to phase I reactions, which often decline in activity. Therefore, glucuronidation can effectively contribute to the clearance of morphine in this patient.

Option B: Hydrolysis is primarily a phase I metabolic reaction that tends to decrease with age, leading to reduced efficacy in drug metabolism for many medications, including morphine derivatives.

Option C: Oxidation is a phase I metabolic reaction that is significantly impacted by aging, often resulting in decreased metabolic capacity and slower drug clearance in older adults.

Option D: Reduction is also a phase I metabolic process that diminishes with age, contributing to altered pharmacokinetics and potential drug accumulation in elderly patients.

Takeaways: Glucuronidation remains intact in elderly patients, allowing for effective morphine metabolism, while phase I reactions like oxidation and reduction decline with age, impacting drug clearance. Understanding these metabolic pathways is crucial for managing medications in older adults, especially those with terminal conditions requiring careful pain management strategies.

Option C: Agonist/Partial 5HT1A agonist accurately describes buspirone's mechanism of action, as it primarily acts as a partial agonist at the 5-HT1A serotonin receptor, which contributes to its anxiolytic effects without the sedative properties typical of benzodiazepines.

Option A: Norepinephrine serotonin reuptake inhibitor misrepresents buspirone's pharmacological profile, as it does not primarily function as a reuptake inhibitor for norepinephrine or serotonin.

Option B: Inhibitor of dopamine & NE reuptake inaccurately describes buspirone, which does not primarily inhibit the reuptake of dopamine or norepinephrine, distinguishing it from other classes of antidepressants.

Option D: Selective serotonin reuptake inhibitor is misleading since buspirone does not selectively inhibit the reuptake of serotonin like SSRIs do, but rather interacts with serotonin receptors directly.

Takeaways: Buspirone functions as a partial agonist at the 5-HT1A receptor, differentiating it from other anxiolytics and highlighting its unique role in anxiety management, which requires understanding its mechanism of action for effective clinical application.

Option D: Metoclopramide is not effective for motion sickness, as it primarily acts on the gastrointestinal tract and central nervous system to enhance gastric motility and reduce nausea related to other causes. Its mechanism does not target the vestibular system, which is involved in motion sickness.

Option A: Cytotoxic and radiation-induced vomiting are effectively managed by metoclopramide, as it helps alleviate nausea and vomiting associated with chemotherapy and radiation therapy by enhancing gastric emptying and acting on central dopamine receptors.

Option B: Post-operative vomiting can be treated with metoclopramide, as it is effective in preventing nausea and vomiting following surgical procedures due to its prokinetic properties and central antiemetic effects.

Option C: Uremia can cause nausea and vomiting, and metoclopramide can be beneficial in these cases by improving gastric motility and reducing symptoms associated with renal failure.

Takeaways: Metoclopramide is effective for various types of nausea and vomiting, but it does not address motion sickness, which requires different treatment approaches. Understanding the specific indications for metoclopramide is crucial for effective patient management, especially in cases of chemotherapy-induced nausea and vomiting.

Option C: Phenytoin demonstrates non-linear (dose-dependent) elimination pharmacokinetics due to saturation of hepatic enzymes at therapeutic and higher concentrations. This results in disproportionate increases in plasma levels with increasing doses, necessitating careful monitoring and dose adjustments in clinical practice.

Option A: Acetylsalicylic acid (aspirin) overdose can lead to zero-order kinetics at high doses, but it primarily follows first-order kinetics at therapeutic levels, making it not a classic example of non-linear elimination.

Option B: Heparin elimination follows first-order kinetics, as its clearance is proportional to the concentration in the plasma, thus not exhibiting non-linear pharmacokinetics.

Option D: Ethanol exhibits zero-order kinetics at higher concentrations, but it is not classified under non-linear elimination in the same context as phenytoin, which is more representative of dose-dependent elimination.

Takeaways: Phenytoin exemplifies non-linear elimination pharmacokinetics due to saturation of metabolic pathways, which requires careful dose management in clinical settings to avoid toxicity.

Option D: The Noyes - Whitney equation describes the rate of drug dissolution from a tablet, relating the dissolution rate to the surface area of the solid, the concentration gradient, and the solubility of the drug in the dissolution medium. This equation is fundamental in pharmacokinetics for understanding how drugs are absorbed in the body.

Option A: Fick's law pertains to diffusion processes and describes how substances move from areas of high concentration to low concentration, but it does not specifically address drug dissolution from tablets.

Option B: The Henderson - Hasselbalch equation is used to calculate the pH of buffer solutions and the ionization of weak acids and bases, which is not directly related to the dissolution rate of drugs from tablets.

Option C: The Law of mass action describes the relationship between the concentrations of reactants and products in a chemical reaction at equilibrium, but it does not specifically apply to the dissolution process of drugs from solid forms.

Takeaways: Understanding the Noyes - Whitney equation is crucial for predicting drug dissolution rates, which impacts bioavailability and therapeutic effectiveness, requiring knowledge of pharmacokinetics and drug formulation in clinical practice.

Option A: Aciclovir inhibits viral DNA polymerase, which is essential for viral replication. This mechanism of action allows it to effectively treat infections caused by herpes viruses, including herpes simplex and varicella-zoster virus. Its specificity for viral enzymes minimizes effects on host cells, making it a cornerstone in antiviral therapy.

Option B: While aciclovir is indicated for various herpes infections, herpetic keratitis specifically requires topical formulations for effective treatment, not systemic aciclovir. Thus, this option does not accurately reflect the standard treatment approach.

Option C: Aciclovir is classified as a category B medication in pregnancy, indicating that it is generally considered safe when the benefits outweigh the risks. Therefore, it should not be avoided if clinically indicated during pregnancy.

Option D: Aciclovir is indeed indicated for herpetic meningoencephalitis; however, this option does not address the primary mechanism of action of the drug, which is the focus of the question. Thus, it does not represent the best answer in this context.

Takeaways: Aciclovir's primary function is to inhibit viral DNA polymerase, making it effective against herpes viruses, including in conditions like herpetic meningoencephalitis, which requires appropriate antiviral therapy for effective management.

Option D: Lipophilicity reduces renal excretion. Lipophilic drugs tend to be reabsorbed in the renal tubules, leading to decreased elimination through urine. This characteristic affects drug clearance and necessitates careful monitoring of drug levels in patients, especially those with renal impairment.

Option A: Absorption is not reduced by lipophilicity; in fact, lipophilic drugs often have enhanced absorption through biological membranes, which are primarily lipid-based.

Option B: Volume of distribution (Vd) is influenced by lipophilicity, but it is not reduced. Lipophilic drugs typically have a larger Vd due to their ability to distribute into body tissues.

Option C: Hepatic elimination is not reduced by lipophilicity; rather, lipophilic drugs may undergo extensive hepatic metabolism, affecting their overall clearance from the body.

Takeaways: Understanding how lipophilicity impacts renal excretion is crucial for pharmacokinetics, as it requires careful monitoring of drug levels in patients with renal impairment to avoid toxicity.

Option C: Dependence is a significant limitation in the use of benzodiazepines for anxiety management. Prolonged use can lead to physical and psychological dependence, resulting in withdrawal symptoms and potential misuse. This concern necessitates careful monitoring and consideration of alternative therapies for long-term anxiety treatment.

Option A: No antidote is available if overdose toxicity occurs. While this is a concern, flumazenil can be used as an antidote in benzodiazepine overdose situations, making this statement misleading.

Option B: Cardiovascular depression is common. Benzodiazepines generally do not cause significant cardiovascular depression, especially in healthy individuals, thus this option does not accurately reflect their primary risks.

Option D: Increased risk of respiratory depression. While respiratory depression can occur, especially in overdose situations or when combined with other CNS depressants, it is not the major limitation compared to the risk of dependence.

Takeaways: Understanding the potential for dependence with benzodiazepine use is crucial for safe prescribing practices, particularly in managing anxiety disorders, which requires careful assessment and monitoring to mitigate risks.